Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ISX:MEDS's ROA % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.555 * Ranked among companies with meaningful ROA % only.
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (. 20) net income data. The Revenue data used here is one times the annual (. 20) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
PT Hetzer Medical Indonesia Tbk ROA % Related Terms
PT Hetzer Medical Indonesia Tbk ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Hetzer Medical Indonesia Tbk ROA % Chart
PT Hetzer Medical Indonesia Tbk Annual Data
Trend
ROA %
PT Hetzer Medical Indonesia Tbk Semi-Annual Data
ROA %
ISX:MEDS vs ISRG, BDX, MDLN: ROA % Comparison
For the Medical Instruments & Supplies subindustry, PT Hetzer Medical Indonesia Tbk's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Hetzer Medical Indonesia Tbk ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Hetzer Medical Indonesia Tbk's ROA % distribution charts can be found below:
* The bar in red indicates where PT Hetzer Medical Indonesia Tbk's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (. 20) net income data.
ROA % is displayed in the 30-year financial page.
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a ROA % of 0.00% as of . 20. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 856 companies in the Medical Devices & Instruments industry.
Is PT Hetzer Medical Indonesia Tbk's ROA % too high?
PT Hetzer Medical Indonesia Tbk's current ROA % is 0.00%. Based on the distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 856 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Hetzer Medical Indonesia Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Hetzer Medical Indonesia Tbk's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 856 companies for ROA %. This places PT Hetzer Medical Indonesia Tbk in the lower half of its industry. The industry median ROA % is 0.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Hetzer Medical Indonesia Tbk's current ROA % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Hetzer Medical Indonesia Tbk stock overvalued right now?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a current ROA % of 0.00%. The current ROA % is 0.00%. PT Hetzer Medical Indonesia Tbk's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For PT Hetzer Medical Indonesia Tbk (ISX:MEDS), the current ROA % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Hetzer Medical Indonesia Tbk Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MEDS has been successfully added to your 
